Fever-Tree is the world's leading supplier of premium carbonated mixers for alcoholic spirits by retail sales value, with distribution to approximately 50 countries internationally.

Based in the UK, the brand was launched in 2005 by Charles Rolls and Tim Warrillow to provide high quality, natural mixers which could accompany the growing demand for premium spirits. The Group now sells a range of 12 differentiated flavours to hotels, restaurants, bars and cafes ("On Trade") as well as supermarkets and off-licenses for retail purchase ("Off Trade"). Approximately 70 per cent. of the Group's sales were derived from outside of the UK in FY13 with the key overseas markets being the US, Spain, and Belgium.

The Group's mixers are designed to be accompaniments for alcoholic spirits or used in cocktails, although they can also be consumed on their own. Since 2005, the Company has launched at least one new product a year, which includes 4 variants of tonic water, 2 variants of ginger beer, 3 variants of lemonade, and one variant each of ginger ale, soda water and cola.

7 November 2014
Admission to AIM and first day of dealings


http://www.fever-tree.com/

i have something of a luxury problem here
my remaining sipp holding is +181% on cost with figures due imminently

on balance, i think i'll stay put, and if there is a chunky "sell on the news", then i may well add once again

Shares -

The 8 largest companies on AIM
1
ASOS
£4.6bn
2
Abcam
£1.8bn
3
Boohoo.com
£1.7bn
4
Fevertree Drinks
£1.7bn
5
Burford Capital
£1.5bn
6
Hutchison China Meditech
£1.4bn
7
Breedon
£1.1bn
8
James Halstead
£1.0bn

Proactive investor - Make mine a double as Fevertree reports
Share
17:27 20 Mar 2017
More good news is expected from star mixer group Fevertree

Sales have grown a huge 73%
Tonic maker Fevertree Drinks PLC (LON:FEVR) announces its preliminary results Tuesday.
Markets already have a rough guide on what to expect, with the London-based firm revealing back in January that it expects full year revenue to come in at around £102mln, 73% higher than what it reported a year earlier.
The company didn’t guide on profits, but Whitman Howard analyst Chris Wickham expects them to come in ahead of expectations, while Shore Capital analyst Phil Carroll is forecasting a pre-tax profit of £36mln.
The consensus is for diluted earnings per share (EPS) to continue its positive momentum and come in at around 24p, although Wickham is predicting 25.2p.
Given Fevertree’s premium valuation, investors will be keeping a close eye on sales so far in 2017, with continued growth vital to underpin the share price.
Upgrades tend to follow Fevertree announcements, and should overall sales growth show no real sign of slowing, this one could follow a similar theme.
The one slight negative in January’s update was that there seemed to be a half-on-half slowdown in growth in continental Europe and in the USA; two big, as yet unrealised opportunities for the company.
Keep an eye on how things have fared in these markets so far in 2017.
There should also be an update on the company’s new mixers. To try and tap the huge American market (where they prefer dark spirits to, say, gin), Fevertree has been working on new ginger beer products so it’ll be interesting to hear how these are coming along.

I'm not looking.

:o)

I hate this share :-)

Me too! Pass the gin please!:o)

Just think of all the gin being consumed from Distil, pushing the sp higher. Leave the tonics to me. :-)) ps you have to like Marmite to love this share. lol

I've just put my jar of Marmite in the bin! Distil has got a bit of catching up to do! :o)

You will have to knock a few more back then.lol

Hic! :o)

Preliminary Results
RNS
RNS Number : 0075A
Fevertree Drinks PLC
21 March 2017
 
21st March 2017
 
Fevertree Drinks plc ("Fever-Tree")
 
Preliminary Results
 
Fever-Tree, the world's leading supplier of premium carbonated mixers, today announces its Preliminary Results for the year ended for 31 December 2016.
 
Financial highlights1:
 
·      Revenue up 73% to £102.2m (2015: £59.3m)
·      Gross profit margin of 55.2% (2015: 52.1%)
·      Adjusted EBITDA up 97% to £35.8m (2015: £18.2m)
·      Robust balance sheet with net cash at year end of £26.9m (2015: £11.6m)
·      Diluted EPS of 23.70 pence (2015: 11.48 pence)
·      Final dividend of 4.71 pence per share recommended to shareholders, bringing total dividend to 6.25 pence per share (2015: 3.08 pence per share)
 
Operational highlights:
 
·      Strong sales growth across all regions, channels and flavours, with a particularly notable performance in the UK
·      Continued penetration in the on-trade and off-trade including new listings with Asda in the UK, Target in the USA and Rewe in Germany
·      Expanded distribution of tonic water with British Airways across entire fleet and achieved listing of Naturally Light Tonic Water cans with EasyJet
·      Launch of new bespoke embossed bottles, successfully rolled out internationally in the period
·      Named the no.1 best-selling and no.1 trending tonic water in Drinks International's survey of world's top 250 bars for the third year running
 
Charles Rolls has today announced his intention to transition from Executive Deputy Chairman to become Non-Executive Deputy Chairman to the Company at the AGM in May 2017.
 
Tim Warrillow, CEO of Fever-Tree said:
 
"2016 has been another exceptional year of growth for Fever-Tree, with strong results achieved across all regions, channels and flavours, emphasising the global appeal of the Fever-Tree brand. As the pioneer and market leader of the premium mixer category, in both market share and reputation, our quality, award winning range of products continues to help drive the momentum towards premiumisation and simple long drink mixability that is transforming both the spirits and mixer categories worldwide.
As co-founder of Fever-Tree, Charles' support and advice will continue to be invaluable to the Company. We have an excellent and growing team in place and I personally look forward to continuing to work with Charles as we further build on the success of the brand that we created together 14 years ago.
We have had an encouraging start to 2017 and remain confident that we are increasingly well positioned to deliver further growth across the business."

 
____________________
1 The Preliminary Results refer to adjusted EBITDA. Adjusted EBITDA for the year ended December 31 2016 is operating profit of £34.4m before depreciation of £0.2m, amortisation of £0.7m and share based payment charges of £0.5m.
 

delighted to see a good chunk of selling on the news .... gave me the chance to top up

"We have had an encouraging start to 2017 and remain confident that we are increasingly well positioned to deliver further growth across the business."

BUT will there be further growth in profits this year?

I still hate this share :-)

21 Mar Shore Capital Buy 1,391.00 - - Reiterates

21 Mar Whitman Howard Hold 1,391.00 1,250.00 1,250.00 Reiterates

Join the club Skinny, have any directors sold and cashed in lately does anyone know?

well my purchase (top-up) this morning is already in the money, so hate this stock as much as you like guys ...... more like green eyes i reckon :-)

I've just taken 45 points from a cheeky S/B - still hate this share :-)

There's no stamp duty with these...why didn't someone tell me )-:

Why didn't you check

I just did, hence the above post.